Mishima, Japan

Shinsuke Yamagata

This inventor holds 4 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1994-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinsuke Yamagata. Retrieved from https://idiyas.com/inventor/shinsuke-yamagata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Osaka, JP (1994)
  • Mishima-gun, JP (1999 - 2001)

Company Filing History:


Years Active: 1994-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shinsuke Yamagata: Innovator in Pharmaceutical Chemistry

Introduction

Shinsuke Yamagata is a notable inventor based in Mishima-gun, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that exhibit therapeutic potential.

Latest Patents

Yamagata holds four patents, with his latest innovations focusing on naphthalene derivatives. These patents include processes for the preparation of naphthalene derivatives, which are characterized by specific chemical formulas. The compounds developed show excellent bronchoconstriction inhibitory activity, making them useful in the prophylaxis or treatment of asthma.

Career Highlights

Yamagata is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical applications. His work has contributed to the understanding and creation of new therapeutic agents.

Collaborations

He has collaborated with notable coworkers, including Katsuo Ikezawa and Tatsuzo Ukita, enhancing the innovative capacity of his projects through teamwork and shared expertise.

Conclusion

Shinsuke Yamagata's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of treatments for respiratory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…